drugset / Trial / NCT00026988
Creatine Therapy for Huntington's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
This study, CREST-HD, will examine the safety and tolerability of 8 grams of creatine in subjects affected by Huntington's disease (HD). Biochemistry and neuroimaging will be used to examine the potential effects of creatine on HD.
Timeline
- Start
- 2001-10
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Creatine | Other / unclassified | 8 g | — |